DHR vs NVDA: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and NVIDIA Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-26.
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
VS
NVIDIA Corporation · Technology
$225.07
+45.0% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
NVDA has more upside to fair value
(+45.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
NVDA |
| Current Price |
$221.12 |
$225.07 |
| Fair Value Estimate |
$286.52 |
$326.35 |
| Upside to Fair Value |
+29.6%
|
+45.0%
|
| Market Cap |
$155.4B |
$5,451.4B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
23.4x
|
| Price / Sales |
6.2x
|
18.0x
|
| Price / FCF |
28.5x
|
42.9x
|
| Revenue Growth YoY |
+5.5%
|
+105.9%
|
| Gross Margin |
58.5%
|
74.7%
|
| Operating Margin |
20.4%
|
65.2%
|
| Return on Equity |
7.7%
|
110.1%
|
| Dividend Yield |
0.65% |
0.23% |
| FCF Yield |
3.51%
|
2.33%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
NVIDIA designs the accelerated computing platforms at the center of the AI buildout, spanning data center GPUs, Mellanox networking, AI enterprise software, gaming GeForce GPUs, professional visualization, and automotive platforms, with 42,000 employees and a $5.45 trillion market capitalization. Business quality is exceptional on the fundamentals: TTM gross margin of 74.7%, TTM operating margin …
Accumulation Zones
| Metric |
DHR |
NVDA |
| Zone Low |
$214.89 |
$244.76 |
| Zone High |
$243.54 |
$277.40 |
| In Buy Zone? |
Yes
|
Yes
|